Outcome of Sorafenib Treatment in Patients With Advanced HCCOutcome of Sorafenib Treatment in Patients With Advanced HCC

Is the tyrosine kinase inhibitor, sorafenib, an effective treatment in patients with advanced hepatocellular carcinoma refractory to chemotherapy? Journal of Gastroenterology and Hepatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news